Rymen D, Jaeken J
Center for Human Genetics, University of Leuven, Leuven, Belgium,
J Inherit Metab Dis. 2014 Sep;37(5):699-708. doi: 10.1007/s10545-014-9678-7. Epub 2014 Feb 20.
The group of congenital disorders of glycosylation (CDG) has expanded tremendously since its first description in 1980, with around 70 distinct disorders described to date. A great phenotypic variability exists, ranging from multisystem disease to single organ involvement. Skin manifestations, although inconsistently present, are part of this broad clinical spectrum. Indeed, the presence of inverted nipples, fat pads and orange peel skin in a patient with developmental delay are considered as a hallmark of CDG, particularly seen in PMM2 deficiency. However, over the years many more dermatological findings have been observed (e.g., ichthyosis, cutis laxa, tumoral calcinosis…). In this review we will discuss the variety of skin manifestations reported in CDG. Moreover, we will explore the possible mechanisms that link a certain glycosylation deficiency to its skin phenotype.
自1980年首次被描述以来,先天性糖基化障碍(CDG)这一疾病群体已大幅扩展,迄今已描述了约70种不同的疾病。其存在巨大的表型变异性,范围从多系统疾病到单器官受累。皮肤表现虽然并非始终出现,但却是这一广泛临床谱的一部分。事实上,发育迟缓患者出现乳头内陷、脂肪垫和橘皮样皮肤被认为是CDG的一个标志,尤其在PMM2缺乏症中可见。然而,多年来观察到了更多的皮肤学表现(如鱼鳞病、皮肤松弛症、肿瘤性钙化……)。在本综述中,我们将讨论CDG中报告的各种皮肤表现。此外,我们将探讨将某种糖基化缺陷与其皮肤表型联系起来的可能机制。